Condition
Hepatic Neoplasm
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Terminated1
Unknown1
Active Not Recruiting1
Completed1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07145801Phase 2Recruiting
Y-90 Treatment Response Using Transarterial Radioembolization
NCT07034950Phase 1Active Not RecruitingPrimary
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
NCT00820456Terminated
Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
NCT04182386UnknownPrimary
Scandinavian Cohort Study for Optimal Use of Portal Vein Embolization
NCT03307811Not ApplicableCompleted
Endoscopic Ultrasound Guided Liver Biopsy
Showing all 5 trials